Author: admin
This Symposium will be hosted live and available on-demandMarch 17-18, 202611:00 AM – 3:00 PM ETCancer treatment is rapidly evolving beyond traditional modalities, driven by breakthroughs in immunotherapy, targeted agents, cell and gene therapies, and next-generation delivery platforms. By integrating these approaches with precision diagnostics, researchers are reshaping oncology and redefining clinical outcomes.In this symposium brought to you by The Scientist, leading experts will discuss advances across the spectrum of emerging cancer therapies, highlighting both preclinical research and translational developments. Paul Mischel, MDProfessor and Vice Chair for ResearchDepartment of PathologyStanford University Neil…
Credit: TopMicrobialStock / iStock / Getty Images Plus Circulating levels of a blood cytokine could help identify patients at particularly high risk of death after contracting a common yeast infection, study findings suggest. The multifunctional cytokine Meteorin-like (METRNL)—also known as interleukin-41—could improve the precision medicine management of fungal disease, the researchers report in Science Translational Medicine. METRNL could be used to guide risk stratification in patients and offers the potential to manage Candida yeast infection through targeted METRNL blocking. In this way, it could be used in a personalized theranostic manner, combining diagnosis and therapy in a single approach. “Our…
Artificial intelligence (AI)-based drug candidates, just like people, need to hit the gym to be at their best, Insilico Medicine reasons. So the newly public AI-based drug developer has launched Science MMAI Gym, a domain-specific training infrastructure designed to transform any “causal” large language model (LLM) like those that predict the next word in a sequence, or most-advanced “frontier” LLM into the best shape for drug discovery and development. Science MMAI Gym is designed to adapt general-purpose LLMs—including ChatGPT, Claude, Gemini, Grok, Llama, Mistral—for training to carry out tasks in medicinal chemistry, biology, and clinical development, with the aim of achieving the precision required for biopharma R&D. Alex Zhavoronkov, PhD, Insilico’s founder, chairman, executive director, and CEO [Insilico]“Insilico is using the…
The Pet Microbiome Boom: Navigating the Growth of Prebiotics, Probiotics and Postbiotics Our host, Sandra Saville IPA’s Director of Education and Communication, sits down with Dr. Jake Burlet, CEO of CanBiocin. Learn about the companion animal industry and hear the incredible story on Canbiocin’s… January 28, 2026 See more
Before picking up a pipette, Nicole Steinmetz, today a biomedical engineer at the University of California San Diego (UCSD), picked up a pair of skates gifted by her grandmother. At the age of five, she was already gliding across public parks and the outdoor skating rinks, alternating between roller skating in the summer and ice skating in the winter. Her affinity for skating caught the attention of coaches, and in her early teens, she was drafted for the German National Team in Artistic Roller Figure Skating.But skating was far from her only love. She aspired to be a scientist. While…
CrispR Cas9 Gene Editing 3D render [Nathan Devery / iStock / Getty Images Plus] A functional genomics analysis using CRISPR-based screening, led by the Wellcome Sanger Institute in the U.K., has identified the loss of expression in two genes—CHD1 and MAP3K7—as potential biomarkers for response to immune checkpoint blockade (ICB) in people with cancer. The findings could be used to predict which patients are most likely to benefit from immunotherapy and open new ways to improve personalized treatment, and outcomes, for these individuals. Although ICB is an effective treatment for many cancer types, including melanoma and tumors with faulty DNA…
For a long time, the large intestine was seen as little more than a waste-processing unit—an organ that prepared undigested food residues for elimination. We knew microbes lived there, but most of them could not be cultured (that is, grown in a lab), so they remained a mystery. Back then, gut health was judged by simple indicators such as regular bowel movements (anywhere from three times a day to once every three days) and appropriate stool consistency (not too hard, not too loose). Everything changed with the arrival of new technologies that allowed us to identify microbes without having to…
A new reusable sensor for real-time in-line glucose monitoring has recently been launched by lab equipment manufacturer Hamilton. The sensor, which the company says is the first of its kind, aims to provide much simpler process monitoring of mammalian cell cultures than existing techniques. “Our customers know Hamilton produces process sensors, and they asked for a way to control glucose that’s as easy-to-handle as our simple oxygen probe,” explains Giovanni Campolongo, senior market segment manager at Hamilton. The new compact probe consists of an optical sensor based on infrared spectrometry, Campolongo explains. It doesn’t require an external spectrometer, which requires…
New membership-based service at Raffles Hotel Arcade blends medical oversight, AI-supported research and high-touch coordination. Singapore’s increasingly crowded longevity and preventive health market has gained a new entrant with the launch of Elyx Life, a concierge-style longevity service based at Raffles Hotel Arcade. Positioned at the intersection of preventive medicine, performance optimization and personalized lifestyle management, the venture reflects a broader shift in how longevity care is being packaged, priced and delivered across Asia’s wealthier urban centers. Founded by technology entrepreneur Peng T Ong alongside Ashish Chordia, Elyx Life is built around a membership model that emphasizes continuous engagement rather…
Traditionally, scientists have used 2D cell cultures as in vitro models in drug screening studies due to their simplicity and scalability. However, 2D cell models do not recapitulate the complexity of in vivo biology, and consequently, many drug candidates have failed as they moved from in vitro experiments to human clinical trials. 3D cell culture lets scientists better simulate the natural complexity of biology, providing more physiologically relevant models that translate to relevant insights in drug discovery.Download this guide to learn how phenotypic 3D cell models can support more predictive insights in drug discovery and translational research.